AXT Stock Falls 22% in Three Months: 3 Reasons the Dip Looks Attractive
AXT, Inc. (AXTI) shares fell 22% in three months, underperforming peers. Despite challenges like export controls, demand for its indium phosphide (InP) substrates remains strong, with Q2 2026 substrate revenues up 232.7% YoY. AXTI is expanding InP capacity and has secured long-term supply agreements, positioning it for AI data-center optical demand growth. The stock trades at a premium P/S ratio of 34.85X.
How this was made
The 30-second read
Why it matters
The article is primarily a dip-and-opportunity thesis, anchored on disclosed capacity expansion commitments, backlog size, and multi-year customer supply agreements with prepayments/deposits, tempered by stated export-related revenue impact and uncertain approval timing.
Market read
Traders may use the disclosed backlog, deposits, and capacity ramp plan to frame downside risk around export approvals and upside around sustained AI optical demand, but the piece does not introduce a fresh, time-specific trigger beyond the described plan.
What to watch
Capacity expansion execution risk (product yield, ramp timing, and 6-inch scale-up) and the possibility that export-control changes affect not just timing but achievable revenue mix.
Background
AXT’s InP substrate business is described as benefiting from AI data-center optical connectivity demand, while its China subsidiary exposure creates sensitivity to tariffs, export controls, and InP export permit timing.
Ticker impact
AXTI is expanding InP capacity and signed multi-year supply agreements, while also flagging export-control uncertainty tied to its Beijing Tongmei unit.
Near-term trading likely remains two-sided: dip-buy interest from capacity and backlog, offset by headline risk around export permits and tariff/export-control changes.
Key disclosed drivers are capacity doubling in 2026, backlog above $100M, and customer prepayments/deposits, but the same text emphasizes that InP revenues have been affected and approval timing is uncertain.
Market effects
Supports the narrative of sustained demand for InP photonics substrates tied to 800G to 1.6T optical connectivity, which can influence sentiment across photonics supply chains.
Highlights China-linked production exposure (Beijing Tongmei) to U.S. export controls, which can keep risk premia elevated for China-dependent semiconductor materials.
AI data-center optical build-out remains a global capex theme, but the article’s incremental impact is company-specific rather than a broad macro shift.
Counterpoint
The valuation premium (trailing P/S 34.85x) plus export-approval uncertainty could mean the market is already pricing the capacity ramp, leaving downside if approvals slip or customer deposits do not translate into timely shipments.
Key entities
- companyAXT, Inc.
Subject of the article, trading as AXT Inc (AXTI), with InP capacity expansion, backlog growth, and export-control-related revenue timing risk.
- subsidiaryBeijing Tongmei
China-based unit whose operations are cited as driving exposure to tariffs, export controls, and InP export permit uncertainty.
- customerCasela
Named customer in a long-term supply agreement committing to purchase about $25.4M of InP wafer substrates during 2027.
- customerCoherent
Named customer in a three-year Master Development and Supply Agreement, including a $22.3M prepayment for 6-inch InP wafer development/supply.
- customerLumentum
Named customer in a six-year Capacity Reservation Agreement with an initial $43.5M deposit and a contemplated second $43.5M deposit in 2028.
